Activity of docetaxel (taxotere) in small cell lung cancerSMYTH, J. F; SMITH, I. E; SESSA, C et al.European journal of cancer. Part A. 1994, Vol 30, Num 8, pp 1058-1060Article

A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancerCLAMP, A. R; SCHOFFSKI, P; JAYSON, G. C et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 579-585, issn 0344-5704, 7 p.Article

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: The European Organisation for Research and Treatment of Cancer ― Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) studyPENEL, N; GLABBEKE, M. V; DUHAMEL, A et al.British journal of cancer. 2011, Vol 104, Num 10, pp 1544-1550, issn 0007-0920, 7 p.Article

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trialHUEBNER, G; LINK, H; BURKART, C et al.British journal of cancer. 2009, Vol 100, Num 1, pp 44-49, issn 0007-0920, 6 p.Article

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancerVAN CUTSEM, E; VAN DE VELDE, H; SAFRAN, H et al.Journal of clinical oncology. 2004, Vol 22, Num 8, pp 1430-1438, issn 0732-183X, 9 p.Article

PATIENT ADHERENCE TO ORAL ANTICANCER DRUGS: AN EMERGING ISSUE IN MODERN ONCOLOGYFOULON, V; SCHÖFFSKI, P; WOLTER, P et al.Acta clinica belgica (Ed. multilingue). 2011, Vol 66, Num 2, pp 85-96, issn 0001-5512, 12 p.Article

Clinical implications of mutational analysis in gastrointestinal stromal tumoursHOEBEN, A; SCHÖFFSKI, P; DEBIEC-RYCHTER, M et al.British journal of cancer. 2008, Vol 98, Num 4, pp 684-688, issn 0007-0920, 5 p.Article

Ästhesioneuroblastom (olfaktorisches neuroblastom) = Olfactory neuroblastomaNÖLLE, C; STÖVER, T; SCHÖFFSKI, P et al.Laryngo-, Rhino-, Otologie. 1998, Vol 77, Num 1, pp 61-64, issn 0935-8943Article

Advanced head and neck cancer and clinical experience of an effective new agent : DocetaxelSCHÖFFSKI, P; WEIHKOPF, T; GANSER, A et al.Anticancer research. 1998, Vol 18, Num 6B, pp 4751-4756, issn 0250-7005Article

Familial occurrence of Leydig cell tumors : a report of a case in a father and his adult sonBOKEMEYER, C; KUCZYK, M; SCHÖFFSKI, P et al.The Journal of urology. 1993, Vol 150, Num 5, pp 1509-1510, issn 0022-5347, 1Article

Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reportsSCHÖFFSKI, P; BUKOWSKI, R; FLODGREN, P et al.Annals of oncology. 2009, Vol 20, issn 0923-7534, i25-i30, SUP1Conference Paper

Repeated administration of short infusions of bendamustine : a phase I study in patients with advanced progressive solid tumoursSCHÖFFSKI, P; HAGEDORN, T; GRÜNWALD, V et al.Journal of cancer research and clinical oncology. 2000, Vol 126, Num 1, pp 41-47, issn 0171-5216Article

Adjuvant therapy for colon adenocarcinoma : current status of clinical investigationKÖHNE-WÖMPNER, C.-H; SCHÖFFSKI, P; SCHMOLL, H.-J et al.Annals of oncology. 1994, Vol 5, pp S97-S104, issn 0923-7534, SUP3Conference Paper

The clinical implications of sunitinib-induced hypothyroidism : a prospective evaluationWOLTER, P; STEFAN, C; DECALLONNE, B et al.British journal of cancer. 2008, Vol 99, Num 3, pp 448-454, issn 0007-0920, 7 p.Article

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationSCHÖFFSKI, P; GANSER, A; PASCHEBERG, U et al.Annals of hematology (Print). 2000, Vol 79, Num 2, pp 95-98, issn 0939-5555Article

Bilateral testicular tumours : prevalence and clinical implicationsBOKEMEYER, C; SCHMOLL, H.-J; SCHÖFFSKI, P et al.European journal of cancer. Part A. 1993, Vol 29, Num 6, pp 874-876Article

Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II studyKÖHNE, C.-H; HARSTRICK, A; HIDDEMANN, W et al.European journal of cancer (1990). 1997, Vol 33, Num 11, pp 1896-1899, issn 0959-8049Article

Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomasBOKEMEYER, C; HARSTRICK, A; SCHMOLL, H.-J et al.Annals of oncology. 1992, Vol 3, Num 6, pp 487-488, issn 0923-7534Article

Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver diseaseTACKE, F; SCHÖFFSKI, P; LUEDDE, T et al.Scandinavian journal of gastroenterology. 2004, Vol 39, Num 3, pp 259-266, issn 0036-5521, 8 p.Article

Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancerBOKEMEYER, C; GERL, A; SCHÖFFSKI, P et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 512-516, issn 0732-183XArticle

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin : randomised studySCHÖFFSKI, P; FREUND, M; WUNDER, R et al.BMJ. British medical journal (International ed.). 1998, Vol 317, Num 7155, pp 379-384, issn 0959-8146Article

Phase II study of rhizoxin in squamous cell head and neck cancerVERWEIJ, J; WANDERS, J; GIL, T et al.British journal of cancer. 1996, Vol 73, Num 3, pp 400-402, issn 0007-0920Article

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumorsBOKEMEYER, C; KÖHRMANN, O; TISCHLER, J et al.Annals of oncology. 1996, Vol 7, Num 10, pp 1015-1021, issn 0923-7534Article

Docetaxel (Taxotere^TM) is active in non-small-cell lung cancer : a phase II trial of the EORTC early clinical trials group (ECTG)CERNY, T; KAPLAN, S; PAVLIDIS, N et al.British journal of cancer. 1994, Vol 70, Num 2, pp 384-387, issn 0007-0920Article

Page / 4